US20120027828A1 - Dental anti-hypersensitivity composition and method - Google Patents
Dental anti-hypersensitivity composition and method Download PDFInfo
- Publication number
- US20120027828A1 US20120027828A1 US13/250,412 US201113250412A US2012027828A1 US 20120027828 A1 US20120027828 A1 US 20120027828A1 US 201113250412 A US201113250412 A US 201113250412A US 2012027828 A1 US2012027828 A1 US 2012027828A1
- Authority
- US
- United States
- Prior art keywords
- arginine
- calcium
- phosphate
- tooth
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 79
- 238000000034 method Methods 0.000 title claims abstract description 49
- 206010020751 Hypersensitivity Diseases 0.000 title claims abstract description 18
- 208000026935 allergic disease Diseases 0.000 title claims abstract description 17
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims abstract description 154
- 229910000019 calcium carbonate Inorganic materials 0.000 claims abstract description 77
- RYJDNPSQBGFFSF-WCCKRBBISA-N (2s)-2-amino-5-(diaminomethylideneamino)pentanoic acid;carbonic acid Chemical group OC(O)=O.OC(=O)[C@@H](N)CCCNC(N)=N RYJDNPSQBGFFSF-WCCKRBBISA-N 0.000 claims abstract description 72
- 210000005239 tubule Anatomy 0.000 claims abstract description 66
- 230000009610 hypersensitivity Effects 0.000 claims abstract description 16
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims abstract description 13
- 230000035945 sensitivity Effects 0.000 claims abstract description 12
- 229910019142 PO4 Inorganic materials 0.000 claims abstract description 11
- 239000010452 phosphate Substances 0.000 claims abstract description 11
- 208000002925 dental caries Diseases 0.000 claims abstract description 10
- 235000010216 calcium carbonate Nutrition 0.000 claims description 71
- 239000004475 Arginine Substances 0.000 claims description 42
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 42
- 239000001506 calcium phosphate Substances 0.000 claims description 32
- 159000000007 calcium salts Chemical class 0.000 claims description 27
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 20
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 210000003298 dental enamel Anatomy 0.000 claims description 15
- 235000013305 food Nutrition 0.000 claims description 14
- -1 guanidinium alkaline salt Chemical class 0.000 claims description 14
- ZRALSGWEFCBTJO-UHFFFAOYSA-O guanidinium Chemical compound NC(N)=[NH2+] ZRALSGWEFCBTJO-UHFFFAOYSA-O 0.000 claims description 11
- 229910000389 calcium phosphate Inorganic materials 0.000 claims description 10
- 239000012458 free base Substances 0.000 claims description 10
- 150000001483 arginine derivatives Chemical class 0.000 claims description 9
- 235000011010 calcium phosphates Nutrition 0.000 claims description 9
- 235000009508 confectionery Nutrition 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 claims description 9
- 235000019739 Dicalciumphosphate Nutrition 0.000 claims description 8
- 239000002585 base Substances 0.000 claims description 8
- 229910000390 dicalcium phosphate Inorganic materials 0.000 claims description 8
- 229940038472 dicalcium phosphate Drugs 0.000 claims description 8
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 7
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 claims description 7
- YYRMJZQKEFZXMX-UHFFFAOYSA-L calcium bis(dihydrogenphosphate) Chemical compound [Ca+2].OP(O)([O-])=O.OP(O)([O-])=O YYRMJZQKEFZXMX-UHFFFAOYSA-L 0.000 claims description 7
- 201000005562 gingival recession Diseases 0.000 claims description 7
- 229910000150 monocalcium phosphate Inorganic materials 0.000 claims description 7
- 235000019691 monocalcium phosphate Nutrition 0.000 claims description 7
- CCTIOCVIZPCTGO-BYPYZUCNSA-N phosphoarginine Chemical compound OC(=O)[C@@H](N)CCCNC(=N)NP(O)(O)=O CCTIOCVIZPCTGO-BYPYZUCNSA-N 0.000 claims description 7
- 229910000391 tricalcium phosphate Inorganic materials 0.000 claims description 7
- 235000019731 tricalcium phosphate Nutrition 0.000 claims description 7
- 229940078499 tricalcium phosphate Drugs 0.000 claims description 7
- WUKWITHWXAAZEY-UHFFFAOYSA-L calcium difluoride Chemical compound [F-].[F-].[Ca+2] WUKWITHWXAAZEY-UHFFFAOYSA-L 0.000 claims description 6
- 229910001634 calcium fluoride Inorganic materials 0.000 claims description 6
- 230000007812 deficiency Effects 0.000 claims description 6
- 239000005022 packaging material Substances 0.000 claims description 5
- HFIGWKOFZLNOQK-UHFFFAOYSA-K [O-]P([O-])(=O)OP(=O)([O-])O.[Ca+2].[Na+] Chemical compound [O-]P([O-])(=O)OP(=O)([O-])O.[Ca+2].[Na+] HFIGWKOFZLNOQK-UHFFFAOYSA-K 0.000 claims description 4
- 229940095626 calcium fluoride Drugs 0.000 claims description 4
- HIAAVKYLDRCDFQ-UHFFFAOYSA-L calcium;dodecanoate Chemical compound [Ca+2].CCCCCCCCCCCC([O-])=O.CCCCCCCCCCCC([O-])=O HIAAVKYLDRCDFQ-UHFFFAOYSA-L 0.000 claims description 4
- GFIKIVSYJDVOOZ-UHFFFAOYSA-L calcium;fluoro-dioxido-oxo-$l^{5}-phosphane Chemical compound [Ca+2].[O-]P([O-])(F)=O GFIKIVSYJDVOOZ-UHFFFAOYSA-L 0.000 claims description 4
- HRBZRZSCMANEHQ-UHFFFAOYSA-L calcium;hexadecanoate Chemical compound [Ca+2].CCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCC([O-])=O HRBZRZSCMANEHQ-UHFFFAOYSA-L 0.000 claims description 4
- 235000003599 food sweetener Nutrition 0.000 claims description 4
- 239000003765 sweetening agent Substances 0.000 claims description 4
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 3
- 229930195725 Mannitol Natural products 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 239000000594 mannitol Substances 0.000 claims description 3
- 235000010355 mannitol Nutrition 0.000 claims description 3
- 108090000623 proteins and genes Proteins 0.000 claims description 3
- 102000004169 proteins and genes Human genes 0.000 claims description 3
- 230000000979 retarding effect Effects 0.000 claims description 3
- 108010011485 Aspartame Proteins 0.000 claims description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 claims description 2
- 239000000605 aspartame Substances 0.000 claims description 2
- 235000010357 aspartame Nutrition 0.000 claims description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 2
- 229960003438 aspartame Drugs 0.000 claims description 2
- 229960001855 mannitol Drugs 0.000 claims description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 claims description 2
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 claims description 2
- 239000000600 sorbitol Substances 0.000 claims description 2
- 235000010356 sorbitol Nutrition 0.000 claims description 2
- 229960002920 sorbitol Drugs 0.000 claims description 2
- 239000000811 xylitol Substances 0.000 claims description 2
- 235000010447 xylitol Nutrition 0.000 claims description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 claims description 2
- 229960002675 xylitol Drugs 0.000 claims description 2
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 claims 7
- 241000628997 Flos Species 0.000 claims 5
- 230000015572 biosynthetic process Effects 0.000 abstract description 19
- 239000012530 fluid Substances 0.000 abstract description 16
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract description 12
- 239000011575 calcium Substances 0.000 abstract description 12
- 229910052791 calcium Inorganic materials 0.000 abstract description 12
- 210000004268 dentin Anatomy 0.000 description 21
- 210000002531 dentinal fluid Anatomy 0.000 description 20
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 12
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 10
- 239000000843 powder Substances 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- 239000002253 acid Substances 0.000 description 9
- 230000001070 adhesive effect Effects 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 239000006072 paste Substances 0.000 description 8
- 239000002245 particle Substances 0.000 description 7
- 241000894006 Bacteria Species 0.000 description 6
- 239000000551 dentifrice Substances 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 210000000214 mouth Anatomy 0.000 description 6
- 239000002002 slurry Substances 0.000 description 6
- 235000017557 sodium bicarbonate Nutrition 0.000 description 6
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 5
- 230000002378 acidificating effect Effects 0.000 description 5
- 239000001569 carbon dioxide Substances 0.000 description 5
- 229910002092 carbon dioxide Inorganic materials 0.000 description 5
- 150000007513 acids Chemical class 0.000 description 4
- 230000002308 calcification Effects 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- 235000010755 mineral Nutrition 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- 239000002324 mouth wash Substances 0.000 description 4
- 239000002244 precipitate Substances 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 238000004448 titration Methods 0.000 description 4
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical class OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 239000008367 deionised water Substances 0.000 description 3
- 229910021641 deionized water Inorganic materials 0.000 description 3
- 239000012153 distilled water Substances 0.000 description 3
- 230000003628 erosive effect Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000013355 food flavoring agent Nutrition 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 230000003902 lesion Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000033001 locomotion Effects 0.000 description 3
- 235000002949 phytic acid Nutrition 0.000 description 3
- 239000004033 plastic Substances 0.000 description 3
- FGIUAXJPYTZDNR-UHFFFAOYSA-N potassium nitrate Inorganic materials [K+].[O-][N+]([O-])=O FGIUAXJPYTZDNR-UHFFFAOYSA-N 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 2
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 2
- 208000002064 Dental Plaque Diseases 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000002776 aggregation Effects 0.000 description 2
- 238000004220 aggregation Methods 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- HAMNKKUPIHEESI-UHFFFAOYSA-N aminoguanidine Chemical compound NNC(N)=N HAMNKKUPIHEESI-UHFFFAOYSA-N 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 229910001424 calcium ion Inorganic materials 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 210000003074 dental pulp Anatomy 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 239000004088 foaming agent Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 210000004126 nerve fiber Anatomy 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 2
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000003296 saliva Anatomy 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- VWDWKYIASSYTQR-UHFFFAOYSA-N sodium nitrate Chemical compound [Na+].[O-][N+]([O-])=O VWDWKYIASSYTQR-UHFFFAOYSA-N 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000000606 toothpaste Substances 0.000 description 2
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 201000011180 Dental Pulp Calcification Diseases 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical class NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- 102000001848 Salivary Proteins and Peptides Human genes 0.000 description 1
- 108010029987 Salivary Proteins and Peptides Proteins 0.000 description 1
- 208000002599 Smear Layer Diseases 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 208000008617 Tooth Demineralization Diseases 0.000 description 1
- 206010072665 Tooth demineralisation Diseases 0.000 description 1
- YJACJDNSRVAQJZ-UHFFFAOYSA-K [Na+].[Ca+2].OC([O-])=O.[O-]C([O-])=O Chemical compound [Na+].[Ca+2].OC([O-])=O.[O-]C([O-])=O YJACJDNSRVAQJZ-UHFFFAOYSA-K 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000003929 acidic solution Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 230000008953 bacterial degradation Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000033558 biomineral tissue development Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- 239000006172 buffering agent Substances 0.000 description 1
- 229940043430 calcium compound Drugs 0.000 description 1
- 150000001674 calcium compounds Chemical class 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- QXDMQSPYEZFLGF-UHFFFAOYSA-L calcium oxalate Chemical group [Ca+2].[O-]C(=O)C([O-])=O QXDMQSPYEZFLGF-UHFFFAOYSA-L 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000005323 carbonate salts Chemical class 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 230000001013 cariogenic effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 230000003196 chaotropic effect Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 235000015218 chewing gum Nutrition 0.000 description 1
- 229940112822 chewing gum Drugs 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 239000003479 dental cement Substances 0.000 description 1
- 239000005548 dental material Substances 0.000 description 1
- 210000004262 dental pulp cavity Anatomy 0.000 description 1
- 201000002170 dentin sensitivity Diseases 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 159000000011 group IA salts Chemical class 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 229920001600 hydrophobic polymer Polymers 0.000 description 1
- 230000002706 hydrostatic effect Effects 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 230000036540 impulse transmission Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- IIPYXGDZVMZOAP-UHFFFAOYSA-N lithium nitrate Inorganic materials [Li+].[O-][N+]([O-])=O IIPYXGDZVMZOAP-UHFFFAOYSA-N 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 210000000412 mechanoreceptor Anatomy 0.000 description 1
- 108091008704 mechanoreceptors Proteins 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000028161 membrane depolarization Effects 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 239000001683 mentha spicata herb oil Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229940051866 mouthwash Drugs 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 230000008904 neural response Effects 0.000 description 1
- 210000004416 odontoblast Anatomy 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 239000004323 potassium nitrate Substances 0.000 description 1
- 235000010333 potassium nitrate Nutrition 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 238000001878 scanning electron micrograph Methods 0.000 description 1
- 238000004626 scanning electron microscopy Methods 0.000 description 1
- 239000000565 sealant Substances 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 238000004088 simulation Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 239000004317 sodium nitrate Substances 0.000 description 1
- 235000010344 sodium nitrate Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000019721 spearmint oil Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 159000000008 strontium salts Chemical class 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000036347 tooth sensitivity Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 239000002966 varnish Substances 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/20—Protective coatings for natural or artificial teeth, e.g. sealings, dye coatings or varnish
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K6/00—Preparations for dentistry
- A61K6/50—Preparations specially adapted for dental root treatment
- A61K6/52—Cleaning; Disinfecting
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0241—Containing particulates characterized by their shape and/or structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
Definitions
- the present invention relates to compositions and methods for preventing or treating dental hypersensitivity.
- the three mineralized tissues of teeth are enamel, cementum and dentine.
- enamel covers the crown dentine whereas cementum covers the root dentine.
- the dentine encloses the pulp of the tooth which provides the dentine with vascular and neural support.
- the dentine is transversed by numerous tubules.
- the tubule walls are comprised of the calcified matrix of the dentine and the tubule space is filled with fluid (dentinal fluid) derived from pulp tissue fluid and serum.
- the matrix mineral is comprised mainly of the calcium phosphate salt, hydroxyapatite, which is poorly soluble at neutral and alkaline pH, and progressively more soluble as the pH becomes progressively more acidic.
- the fluid that fills the narrow dentinal tubules enables cold, tactile, evaporative and osmotic stimuli to be transmitted through the dentine to the pulp in the form of fluid movement.
- This movement of dentinal fluid is sensed as sharp pain of short duration.
- This pain is elicited when the odontoblasts that protrude into the pulpal ends of the tubules are disturbed and as a result, the mechano-receptors of the pulpal nerve fibers attached thereto are stimulated.
- the neural response is usually referred to as dentinal pain and the involved dentine as hypersensitive dentine.
- Dentinal hypersensitivity results when protective enamel or cementum covering dentine is lost. Cementum is easier to breach than enamel, because cementum is thinner and more easily eroded by acids. However, breach of cementum cannot happen until there is gingival recession and exposure of the root surface to the oral milieu. Individuals with breached cementum and suffering with dentinal hypersensitivity often experience pain when the exposed area of the tooth comes into contact with cold air or hot and cold liquids or foods that are sweet or acidic or is touched with a metal object.
- Substances other than calcium phosphate have also been utilized.
- U.S. Pat. No. 3,683,006 to Hodosh describes using potassium, lithium or sodium nitrate.
- Another example is calcium oxalate particles of small and large size.
- Application of a protein denaturing agent, such as an alcohol, a surfactant, or a chaotropic salt can also plug an exposed dentinal tubule since there is protein material within the dentinal tubules and denaturation can sometimes result in partial or complete tubule plugging.
- Still another but more drastic approach is to place a dental restoration in the affected area or cover the area with an adhesive material.
- compositions and methods for blocking exposed dentinal tubules to treat dentinal hypersensitivity are acute need in the art for compositions and methods for blocking exposed dentinal tubules to treat dentinal hypersensitivity.
- compositions and methods that can achieve intrinsic blockage of dentinal tubules, e.g., by taking advantage of the presence of calcium and phosphate ions in dentinal fluid, which potentiates their ability to precipitate as a calcium phosphate salt and achieve tubule blockage.
- the present invention advantageously provides such compositions and methods.
- the present invention advantageously provides an oral composition comprising a guanidinium alkaline salt and a calcium salt and an orally acceptable carrier, wherein the pH of the composition ranges from about 7.5 to about 9.5, and the calcium salt is poorly soluble in water.
- the oral composition consists essentially of the guanidinium alkaline salt and poorly soluble calcium salt with an orally acceptable carrier.
- the oral composition substantially lacks any phytates.
- the guanidinium is arginine and the calcium salt is calcium carbonate.
- the invention further provides a powder composition
- a powder composition comprising, or more particularly consisting essentially of, an arginine salt (or equivalent guanidinium salt) and calcium carbonate (or an equivalent poorly soluble calcium salt).
- a powder composition when in contact with a calcium phosphate solution or slurry, or a body fluid (e.g., dentinal fluid, saliva, or pulpal fluid), body cells, or body tissues (e.g., dental pulp), yields a pH ranging from about 7.5 to about 9.5.
- the powder composition lacks phytates.
- the invention provides a pulpal calcification filling comprising, or more particularly consisting essentially of an arginine salt (or an equivalent guanidinium salt) and calcium carbonate (or an equivalent poorly soluble calcium salt) and a filling carrier, wherein the pH of the composition ranges from about 7.5 to about 9.5.
- the invention further provides methods for treating or preventing dentinal sensitivity, plugging tubules, treating a carious lesion, calcifying an exposed tooth pulp, and calcifying the base or all of a pit or fissure in a tooth.
- the methods comprise administering a composition comprising, or more particularly consisting essentially of an arginine (or equivalent guanidinium) salt and calcium carbonate (or an equivalent poorly soluble calcium salt), wherein a pH of the composition ranges from about 7.5 to about 9.5, to the affected area.
- the invention has as a further object a composition for reducing dentinal sensitivity.
- Another object of the invention is to provide methods for calcifying dental lesions, including dentinal tubules, exposed tooth pulp, carious lesions, and pits or fissures.
- FIG. 1 Titration of artificial dentinal fluid with arginine bicarbonate (ArgHCO 3 ) solution.
- FIG. 2 Titration of artificial dentinal fluid with the supernatant of an arginine bicarbonate/calcium carbonate powder suspension.
- FIG. 1 Titration of artificial dentinal fluid with the supernatant of a calcium carbonate (CaCO 3 ) suspension.
- FIG. 4 Titration of artificial dentinal fluid with sodium hydroxide (NaOH) solution.
- FIGS. 5A and 5B Scanning electron photomicrograph showing (A) dentinal tubules after exposure to arginine bicarbonate/calcium carbonate powder suspension, and (B) control prior to exposure.
- FIGS. 6A and 613 Scanning electron photomicrograph showing (A) dentinal tubules after exposure to calcium carbonate powder suspension, and (B) control prior to exposure.
- FIGS. 7A and 713 Scanning electron photomicrograph showing (A) dentinal tubules after exposure to arginine bicarbonate, and (B) control prior to exposure.
- the present invention has identified an oral composition unlike the oral compositions previously identified, capable of reducing or preventing dentinal hypersensitivity. It has been discovered by the present invention that an oral composition containing, and preferably consisting essentially of, arginine bicarbonate (or equivalents thereof) and calcium carbonate (or equivalents thereof) promotes the formation of dentinal tubule plugs aided by combining calcium and phosphate in the fluid. It has also been discovered by the present invention that an oral composition containing arginine bicarbonate and calcium carbonate promotes the formation of salivary precipitin, a carbohydrate-protein-calcium phosphate complex present primarily in dental plaque, which is formed from saliva when salivary proteins combine with calcium and phosphate, to reduce or prevent dentinal hypersensitivity.
- Arginine bicarbonate and calcium carbonate are the preferred components of compositions of the invention. However, compounds with equivalent or closely related properties can substitute for arginine bicarbonate. Other arginine compounds that can be used include, but are not limited to, arginine hydroxide, arginine carbonate, arginine phosphate, and arginine organic phosphate. Although arginine phytate may be used, preferably it is avoided except at high pH. Arginine bicarbonate is a guanidinium alkaline carbonate salt; other such salts may be used in its place. Examples include aminoguanidine and aminoguanidinium analogues.
- calcium compounds with equivalent or closely related solubilities can substitute for calcium carbonate or part of it.
- These include monocalcium phosphate, dicalcium phosphate, tricalcium phosphate, calcium fluoride, calcium monofluorophosphate, sodium calcium pyrophosphate, calcium laurate, and calcium palmitate.
- the present invention relates to a method of reducing or preventing tooth hypersensitivity by delivering into the oral cavity an oral composition containing a therapeutically effective amount of arginine bicarbonate and calcium carbonate distributed in an oral vehicle.
- the amount of arginine bicarbonate and calcium carbonate sufficient to reduce or prevent dentinal hypersensitivity is an amount sufficient to promote dentinal plugging. It has been discovered that arginine bicarbonate and calcium carbonate promote the formation of and provide particles in the oral cavity for plugging the dentinal tubules of teeth. By plugging the dentinal tubules, the oral compositions used in the method of this invention are capable of reducing dentinal hypersensitivity.
- Calcium carbonate is a poorly soluble calcium salt which is defined here as one having a solubility of about 0.1 to about 100 mg in 100 ml of water at room temperature near or above a pH of about 5, and especially above neutral pH.
- Arginine bicarbonate and calcium carbonate are well suited for promoting dentinal plugging for a number of reasons. For one thing, they are effective neutralizers of acid especially since they can lose carbon dioxide and produce arginine hydroxide (arginine free base) and calcium hydroxide, respectively, when they come in contact with acid; this and being alkaline salts results in a rapid and substantial rise in the pH that is particularly favorable to deposit formation.
- a second reason is that calcium carbonate is poorly soluble above neutrality but is progressively more soluble as the pH becomes acidic. This behavior is similar to that of the calcium phosphate in tooth mineral tissues, thereby enabling the calcium carbonate to provide a renewable reservoir of calcium to reduce or prevent erosion of the cementum and dentine.
- a third reason is that arginine bicarbonate surprisingly has adhesive properties particularly useful at a pH ranging from about 7.5 to about 9.5, and preferably 8 to about 9 or 9.5. Together with the poor solubility of calcium carbonate or a like calcium salt, the arginine bicarbonate combination favors plugging of open dentinal tubules by binding of calcium carbonate particles and their attachment to the tubule walls and tooth surface. Demonstration of plugging effectiveness in an actual dentine plugging model shows the arginine bicarbonate/calcium carbonate combination is significantly superior. This means of plugging tubules is different from the prior art, where formation of tubule plugs is attempted by producing calcium phosphate precipitates from acidic solutions of moderately to highly soluble calcium and phosphate salt solutions or the like.
- Dentinal sensitivity resulting from the acids generated by bacteria is really an early stage in the development of a dental caries lesion.
- the bacteria found at the distal ends of tubules exposed to the oral environment are the same as those found in dental plaque.
- the preferred bicarbonate cation is arginine since it will favor the base forming metabolism and the growth of arginolytic rather than non-arginolytic bacteria.
- the former are more alkalogenic and less cariogenic than the non-arginolytic bacteria. This additional factor will ensure sustenance of an elevated pH and a reservoir of alkali generation capability within and in association with the dentinal tubules.
- the preferred composition of arginine bicarbonate combined with calcium carbonate has a number of effects. It neutralizes any acid in the tubules, ensures a pH above neutrality and as high as, and in a specific embodiment greater than, about 9.0, provides needed calcium ions, provides a poorly soluble salt that has a small particle size to facilitate filling and plugging the dentinal tubules, and provides arginine to favor growth of and alkali production by alkalogenic bacteria for maintenance of an alkaline pH.
- arginine bicarbonate in the preferred pH range of use has been found unexpectedly to have adhesive properties that favor tubule plugging, an important property in light of the fact that in vivo flow of dentinal fluid out of the dentinal tubules under pressure makes any plugging difficult.
- the terms “about” and “approximately” mean within 20%, preferably within 10%, and more preferably within 5% of a given value, unless another definition is provided.
- the present invention provides an oral composition containing therapeutic amounts of arginine bicarbonate and calcium carbonate distributed in an acceptable oral vehicle.
- the oral compositions of this invention by weight may contain, for example, arginine bicarbonate in a concentration ranging from about 1 to about 25% and calcium carbonate in a concentration ranging from about 5 to about 50%.
- the oral composition further contains a therapeutically effective amount of fluoride, for example, 10 to 1500 ppm. Any conventional ingredients for the particular oral vehicle may further be added to the oral compositions of the present invention.
- the pH of the oral compositions of the present invention generally ranges from about 7.5 to about 9.5, preferably from about 8.0 to about 9.0, where arginine bicarbonate exhibits adhesive properties.
- the pH of the oral compositions described herein can be lowered with arginine bicarbonate or acid such as hydrochloric, or raised with arginine hydroxide (arginine free base) or bases such as sodium hydroxide or buffering agents such as sodium bicarbonate.
- the oral compositions of this invention may contain any conventional ingredient thr the particular oral vehicle discussed herein.
- the amount of calcium carbonate and arginine bicarbonate sufficient to reduce or prevent dentinal hypersensitivity varies with the type of oral vehicle used to deliver the therapeutic agent.
- the oral vehicles described by the present invention contain between approximately 5 grams to 50 grams of calcium carbonate and between approximately 1 gram to 25 grams of arginine bicarbonate per 100 grams oral composition.
- the oral compositions used in the method of this invention contain a therapeutically effective amount of fluoride.
- the concentration of fluoride generally ranges from approximately 10 to 1500 ppm.
- Calcium fluoride is a preferred form of fluoride because it can be incorporated into a tubule plug along with calcium carbonate largely as particles, where fluoride ions along with calcium ions can be slowly released over prolonged periods of time. Despite its low solubility, calcium fluoride provides a source of calcium and fluoride ions and the ability to develop a less acid soluble tubule plug than if absent.
- Acceptable oral vehicles include any conventional oral delivery system, such as dental care products, food products, and chewing gum.
- dental care products include, for example, dentifrices, topical solutions or pastes, mouthwashes in the form of liquids or sprays or slurries, powders, gels or tablets, and dental flosses.
- food products which may contain oral compositions described herein include, for example, lozenges and confections.
- liquid mouthwashes may contain solvents such as distilled or deionized water and ethanol; a sweetening agent such as saccharine, aspartame, sorbitol, mannitol, and xylitol; and a flavoring agent such as peppermint oil and spearmint oil (see U.S. Pat. Nos. 4,226,851 and 4,606,912).
- Dentifrices may contain, for example, a conventional abrasive such as resins, silica, and insoluble alkali metal metaphosphates in a standard amount of about 20% to about 60% by weight; a binder such as hydroxyethylcellulose, xanthin gum, and sodium carboxymethylcellulose in a standard amount ranging from about 0.5% to about 5.0% by weight; a foaming agent such as sodium lauryl sulfate, sodium coconut monoglyceride sulfonate, and sodium-N-methyl-N-palmitoyl taurine in a standard amount ranging from about 0.5% to about 3.0% by weight; a flavoring agent; a sweetening agent; an antiseptic agent and any other ingredient required for the particular composition as recognized by those skilled in the art (see U.S.
- a conventional abrasive such as resins, silica, and insoluble alkali metal metaphosphates in a standard amount of about 20% to about 60% by weight
- a binder such as
- Tablets and powders may contain, for example, a vehicle such as lactose and mannitol, a binder such as corn starch and carboxymethylcellulose, and a disintegrator.
- a vehicle such as lactose and mannitol
- a binder such as corn starch and carboxymethylcellulose
- a dentifrice or paste for localized application to a sensitive tooth site such as breeched cementum of an orally exposed root surface may be one that is simpler in composition and applied with a soft applicator.
- a dentifrice or paste may or may not contain conventional abrasive, foaming agent, and flavoring agents.
- Localized sites such as the dentine following tooth preparation for a dental restoration would also involve simpler compositions and include fillers used in dental pulp cappings, cavity liners and cements and any other ingredients required for the composition by those skilled in the art (Craig et al., 1989, Restorative Dental Materials. Mosby, St. Louis, pp. 189-225). For example, zinc oxide and eugenol at levels of (20 and 25%, respectively) would be appropriate for dental cement compositions.
- the oral compositions described herein be produced by adding arginine bicarbonate having a concentration by weight ranging from about 1 to about 25% and calcium carbonate having a concentration by weight ranging from about 5 to about 50% to an acceptable oral vehicle using conventional techniques.
- the pH of the composition may range from approximately 7.5 to approximately 9.5, preferably approximately 8.0 to approximately 9.0.
- the amount of arginine bicarbonate and calcium carbonate to retard or prevent dentinal hypersensitivity is an amount sufficient to plug the exposed dentinal tubules in teeth in the oral cavity by promoting the formation of dentinal plugs.
- a dentifrice or paste may contain arginine bicarbonate and calcium carbonate in a concentration ranging from about 1 to about 25% and about 5 to about 50%, respectively.
- a mouthwash or slurry may also contain arginine bicarbonate and calcium carbonate in a concentration ranging from about 1 to about 25% and about 5 to about 50%, respectively.
- the present invention further provides an article of manufacture comprising a packaging material and the oral compositions described herein contained within said packaging material, wherein said oral composition is effective in retarding or preventing dentinal hypersensitivity and wherein said packaging material contains a label that indicates that said oral composition is effective in retarding or preventing dentinal hypersensitivity.
- the packaging material used to contain the oral compositions can comprise glass, plastic, metal or any other suitably inert material.
- dentifrice containing the oral composition of the present invention may be contained in a collapsible tube, typically aluminum, line lead or plastic or a squeeze pump or pressurized dispenser to measure out the contents or in a tearable sachet.
- the oral composition of the present invention may also be used in a prophylaxis paste for polishing teeth or treating sensitive teeth or preventing the development of sensitive teeth after scaling, root planing or stain removal by a dentist or hygienist, in a small dental container, such as a tub of a size that permits easy access of the rotary attachments used in dental offices on dental hand-pieces.
- the present invention is directed to a method for promoting the formation of dentinal tubule plugs by delivering into the oral cavity an oral composition containing arginine bicarbonate and calcium carbonate.
- the present invention is further directed to a method for promoting the formation of salivary precipitin in the oral cavity by delivering into the oral cavity an oral composition containing arginine bicarbonate and calcium carbonate.
- the oral compositions used in this method may contain any conventional ingredient for the particular oral vehicle as outlined above.
- the oral compositions used in this method contain a therapeutically effective amount of fluoride, generally between about 10 to about 1500 ppm.
- the oral compositions contain arginine bicarbonate in an amount ranging from about 1 to about 25% and calcium carbonate in the amount ranging from about 5 to about 50%,
- tubule plugging with arginine bicarbonate/calcium carbonate to stop dentinal fluid flow is desirable to enable proper placement of a non-leaking cavity liner, dental filling, or crown.
- Wetness, because of leakage of dentinal fluid, will often result in poor sealing of these devices or appliances. This is why sensitivity often persists and does so until natural tubule plugging or tooth pathology and demise occurs.
- Powder compositions of arginine bicarbonate/calcium carbonate provided in slurries or pastes are suitable for the formation of tubule plugs and use as a cavity lining material. Since dentinal fluid is derived from pulpal fluid, the arginine bicarbonate/calcium carbonate composition can provide the exposed pulp with a capping at the same time that adjacent open tubules are plugged.
- a related application is the calcification or mineralization of pits and fissures, which are sites where oral stimuli have access to underlying dentinal tubules because the enamel at their bases or sides is breeched as a result of tooth formation deficiencies or because of dental caries.
- pits and fissures are sites where oral stimuli have access to underlying dentinal tubules because the enamel at their bases or sides is breeched as a result of tooth formation deficiencies or because of dental caries.
- pulp fluid which is the source of dentinal fluid
- pulp fluid contains calcium and phosphate so that it is amenable to calcification and sealing off the pulp from the oral environment.
- a slurry or paste containing arginine bicarbonate/calcium carbonate to an exposed pulp will suffice. This can also be placed into a pulp chamber from which pulp tissue has been removed.
- compositions that stimulate intrinsic blockage of the dentinal tubule In this case, formation of a deposit uses tubule contents. Being a tissue fluid, dentinal fluid contains calcium and phosphate ions, which makes it amenable to calcification.
- Dentine discs that varied in thickness from 0.6 to 0.8 mm were cut with a Buhler Isomet saw from extracted caries-free molar teeth. They were then etched with 6% citric acid for two minutes to remove the smear layer and stored in 70% ethanol until used.
- a disc was mounted in the chamber of the apparatus with occlusal side facing upwards. The occlusal side is determined by passing light through a plastic grid beneath the section and observing the section with a dissecting microscope.
- tubules appear further apart with the occlusal side up because of the lower tubular density of the dentine occlusally (Walton et al., J. Dental Research 55:639-642, 1976). Hydraulic conductance of fluid through the discs was determined as described by Greenhill and Pashley, supra.
- Fluid containing levels of ions present in serum was used to perfuse the disc. Their concentrations in mM were as follows: Na—140.5, K—4.31, Ca—2.5, Mg—1.0, P—1.3. The pH of this solution is raised to 7.0 with sodium hydroxide. The solution was filtered through a 0.22 mm filter (Millipore Corp., Marlborough, Mass. 01752) prior to use to remove any bacteria present. This solution is called artificial ionic dentinal fluid (AIDF). Hydrostatic pressure was created by a fluid reservoir leading via a glass capillary tube into the pulpal side of the chamber at a level 30 cm above that of the surface of the horizontally positioned disc.
- Sections were exposed to an arginine bicarbonate/calcium carbonate mixture and various controls as follows. First, 400 ml of AIDF was applied to the upward facing occlusal side of the section and AIDF was allowed to flow through the disc from the pulpal side for a period of five minutes. The distance that the air bubble moved inside the capillary on the pulpal side of the chamber was measured so that the rate of fluid movement through the disc could be calculated and converted to hydraulic conductance values. This procedure was repeated two more times or until a uniform flow rate was achieved on three consecutive runs. The AIDF was then replaced by 400 ⁇ l of a 1:4 arginine bicarbonate/calcium carbonate slurry and brushed on the dentine surface for two minutes.
- the mixture was removed with a pipette, washed three times with 400 ⁇ l of deionized water and replaced with AIDF.
- the AIDF was allowed to flow through the dentine slice and hydraulic conductance readings were made at selected times up to 90 minutes.
- New dentin sections were selected and the experiment repeated using either (i) sodium bicarbonate plus calcium carbonate in the same ratio as the arginine bicarbonate/calcium carbonate mixture, (ii) arginine bicarbonate alone, (iii) sodium bicarbonate (iv) calcium carbonate alone, or (v) distilled water.
- Table 1 shows the results. The hydraulic conductance fell the most with the arginine bicarbonate/calcium carbonate mixture. Calcium carbonate, arginine bicarbonate, distilled water and combining sodium bicarbonate and calcium carbonate had much smaller effects, in some cases, a negative result (i.e. an increase in conductance) was seen. Examination of the discs by scanning electron microscopy revealed substantial blockage of the orifices of the dentinal tubules with the arginine bicarbonate/calcium carbonate mixture but little or no blockage with the other test substances shown in the table. Blockage of dentinal tubules is considered central to reduction of dentinal hypersensitivity.
- Arginine bicarbonate has adhesive properties desirable for plugging dentinal tubules.
- Arginine bicarbonate is prepared from arginine (free base) by titrating the arginine with gaseous carbon dioxide as follows. 7.5 g of arginine is dissolved in 50 ml of deionized water and has a pH of about 10.6. Then carbon dioxide is delivered thereto under pressure (2 lbs./sq. in.) from a commercial gas cylinder until a solution pH of 7.2 is reached. This is the pH at which the carbon dioxide has converted all or most of the arginine to arginine bicarbonate. For intrinsic plugging and the formation of salivary precipitin, a pH between 8 and 9 is preferred.
- arginine bicarbonate This is done by titrating the arginine with carbon dioxide to a desired pH between 8 and 9 or by mixing of the arginine bicarbonate with the more alkaline arginine free base to a desired pH between 8 and 9.
- the adhesive properties of arginine bicarbonate are retained as well as the ability to produce intrinsic plugging and promotion of salivary precipitin formation.
- FIGS. 5A , 6 A, 7A Scanning electron micrographs show the ability of arginine bicarbonate plus calcium carbonate to plug open dentinal tubules ( FIG. 5A ) compared to calcium carbonate alone ( FIG. 6A ) and arginine bicarbonate alone ( FIG. 7A ).
- Control samples FIGS. 5B , 6 B, 7 B
- calcium carbonate is a poorly soluble calcium salt, its small particle size and interaction with arginine bicarbonate make the combination suitable for plugging open dentinal tubules.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Dental Preparations (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The present invention relates to compositions and methods for calcifying dental tissue, e.g., preventing or treating dental hypersensitivity. An oral composition of arginine bicarbonate and calcium carbonate promotes the formation of dentinal tubule plugs aided by combining calcium and phosphate in the fluid. In a specific example, an arginine bicarbonate/calcium carbonate mixture blocked dentinal tubules in a model system. In addition to treating dentinal sensitivity, the compositions and methods of the invention provide for calcifying exposed tooth pulp, calcifying the base or all of a pit or fissure in a tooth, and treating a carious lesion.
Description
- This application is a continuation of U.S. Ser. No. 10/328,389 filed Dec. 23, 2002; which is a continuation of U.S. Ser. No. 09/940,723 filed Aug. 27, 2001; now issued U.S. Pat. No. 6,524,558; which is a continuation of U.S. Ser. No. 09/504,264 filed Feb. 15, 2000, now issued U.S. Pat. No. 6,436,370; which claims priority to U.S. Provisional Application No. 60/140,560 filed Jun. 23, 1999, all incorporated herein by reference.
- The present invention relates to compositions and methods for preventing or treating dental hypersensitivity.
- The three mineralized tissues of teeth are enamel, cementum and dentine. In human teeth, enamel covers the crown dentine whereas cementum covers the root dentine. In turn, the dentine encloses the pulp of the tooth which provides the dentine with vascular and neural support. Unlike enamel and cementum, the dentine is transversed by numerous tubules. The tubule walls are comprised of the calcified matrix of the dentine and the tubule space is filled with fluid (dentinal fluid) derived from pulp tissue fluid and serum. The matrix mineral is comprised mainly of the calcium phosphate salt, hydroxyapatite, which is poorly soluble at neutral and alkaline pH, and progressively more soluble as the pH becomes progressively more acidic.
- Because of their rigid walls, the fluid that fills the narrow dentinal tubules enables cold, tactile, evaporative and osmotic stimuli to be transmitted through the dentine to the pulp in the form of fluid movement. This movement of dentinal fluid is sensed as sharp pain of short duration. This pain is elicited when the odontoblasts that protrude into the pulpal ends of the tubules are disturbed and as a result, the mechano-receptors of the pulpal nerve fibers attached thereto are stimulated. The neural response is usually referred to as dentinal pain and the involved dentine as hypersensitive dentine.
- Dentinal hypersensitivity results when protective enamel or cementum covering dentine is lost. Cementum is easier to breach than enamel, because cementum is thinner and more easily eroded by acids. However, breach of cementum cannot happen until there is gingival recession and exposure of the root surface to the oral milieu. Individuals with breached cementum and suffering with dentinal hypersensitivity often experience pain when the exposed area of the tooth comes into contact with cold air or hot and cold liquids or foods that are sweet or acidic or is touched with a metal object.
- One way that loss of cementum occurs (and the same is true of enamel) is by the process of dental caries. Acids are produced as end-products of the bacterial degradation of fermentable carbohydrate and these acids dissolve hydroxyapatite, which, like dentine and enamel, is the main calcium phosphate mineral that comprises most of the mineral of the cementum. Another source is acidic foods which, if ingested frequently and for prolonged periods of time, will cause tooth demineralization. These include fruit juices and many beverages, both alcoholic and non-alcoholic. Other acidic agents leading to chemical erosion include various oral personal care products. Amongst these are many of the commercially available mouthwashes and some toothpastes. Abrasive toothpastes and vigorous brushing can aid the erosion process. Another way in which dentinal tubules lose their protective cementum and enamel coverings is through procedures performed by the dentist or hygienist in the dental office. This includes cavity and crown preparation of teeth for fillings and other restorations. It also includes cementum removal during scaling and root planing by the periodontist or dental hygienist.
- Many attempts have been made with limited success to plug exposed dentinal tubules and to thereby reduce or stop the ability of stimuli to reach the pulp and cause pain. Materials either singly or in combination have been tried to produce an effective plug. Blockage of the tubules through the formation of a calcium phosphate precipitate is a common approach. This includes the mixing of a soluble calcium salt with a soluble phosphate salt and immediately applying the combination to the open tubules. Alternatively, application of one salt before the other to try to get a precipitate to form within tubules is also used.
- Substances other than calcium phosphate have also been utilized. For example, U.S. Pat. No. 3,683,006 to Hodosh describes using potassium, lithium or sodium nitrate. Another example is calcium oxalate particles of small and large size. Application of a protein denaturing agent, such as an alcohol, a surfactant, or a chaotropic salt, can also plug an exposed dentinal tubule since there is protein material within the dentinal tubules and denaturation can sometimes result in partial or complete tubule plugging. Still another but more drastic approach is to place a dental restoration in the affected area or cover the area with an adhesive material. For example, U.S. Pat. No. 5,139,768 to Friedman describes using a varnish containing strontium salt in a sustained hydrophobic polymer. Adherence without leakage of fluid from the tubules is not always easy to accomplish because adherence to a wet surface is difficult to achieve considering that the continual outward flow or leakage of dentinal fluid from the tubules while a filling or adhesive is setting is hard to stop.
- Attempts to treat tooth sensitivity other than by plugging have involved depolarization of the nerve fiber membranes essential for nerve impulse transmission. Potassium salts, especially potassium nitrate, have been largely used for this purpose. For example, U.S. Pat. Nos. 4,751,072 and 4,631,185 to Kim describe using potassium bicarbonate and potassium chloride.
- Thus, there remains acute need in the art for compositions and methods for blocking exposed dentinal tubules to treat dentinal hypersensitivity.
- There is a further need in the art to identify compositions and methods that can achieve intrinsic blockage of dentinal tubules, e.g., by taking advantage of the presence of calcium and phosphate ions in dentinal fluid, which potentiates their ability to precipitate as a calcium phosphate salt and achieve tubule blockage.
- The present invention advantageously provides such compositions and methods.
- The present invention advantageously provides an oral composition comprising a guanidinium alkaline salt and a calcium salt and an orally acceptable carrier, wherein the pH of the composition ranges from about 7.5 to about 9.5, and the calcium salt is poorly soluble in water. In a more specific embodiment, the oral composition consists essentially of the guanidinium alkaline salt and poorly soluble calcium salt with an orally acceptable carrier. In yet a further embodiment, the oral composition substantially lacks any phytates. Preferably, the guanidinium is arginine and the calcium salt is calcium carbonate.
- The invention further provides a powder composition comprising, or more particularly consisting essentially of, an arginine salt (or equivalent guanidinium salt) and calcium carbonate (or an equivalent poorly soluble calcium salt). Such a powder composition, when in contact with a calcium phosphate solution or slurry, or a body fluid (e.g., dentinal fluid, saliva, or pulpal fluid), body cells, or body tissues (e.g., dental pulp), yields a pH ranging from about 7.5 to about 9.5. Preferably, the powder composition lacks phytates.
- In a further aspect, the invention provides a pulpal calcification filling comprising, or more particularly consisting essentially of an arginine salt (or an equivalent guanidinium salt) and calcium carbonate (or an equivalent poorly soluble calcium salt) and a filling carrier, wherein the pH of the composition ranges from about 7.5 to about 9.5.
- The invention further provides methods for treating or preventing dentinal sensitivity, plugging tubules, treating a carious lesion, calcifying an exposed tooth pulp, and calcifying the base or all of a pit or fissure in a tooth. The methods comprise administering a composition comprising, or more particularly consisting essentially of an arginine (or equivalent guanidinium) salt and calcium carbonate (or an equivalent poorly soluble calcium salt), wherein a pH of the composition ranges from about 7.5 to about 9.5, to the affected area.
- Thus, it is an object of the invention to provide a composition suitable to calcify dental lesions.
- The invention has as a further object a composition for reducing dentinal sensitivity.
- Another object of the invention is to provide methods for calcifying dental lesions, including dentinal tubules, exposed tooth pulp, carious lesions, and pits or fissures.
- These and other objects of the invention have been achieved as further elaborated in the accompanying Drawings, Detailed Description of the Invention, and Examples.
-
FIG. 1 . Titration of artificial dentinal fluid with arginine bicarbonate (ArgHCO3) solution. -
FIG. 2 . Titration of artificial dentinal fluid with the supernatant of an arginine bicarbonate/calcium carbonate powder suspension. -
FIG. 1 Titration of artificial dentinal fluid with the supernatant of a calcium carbonate (CaCO3) suspension. -
FIG. 4 . Titration of artificial dentinal fluid with sodium hydroxide (NaOH) solution. -
FIGS. 5A and 5B . Scanning electron photomicrograph showing (A) dentinal tubules after exposure to arginine bicarbonate/calcium carbonate powder suspension, and (B) control prior to exposure. -
FIGS. 6A and 613 . Scanning electron photomicrograph showing (A) dentinal tubules after exposure to calcium carbonate powder suspension, and (B) control prior to exposure. -
FIGS. 7A and 713 . Scanning electron photomicrograph showing (A) dentinal tubules after exposure to arginine bicarbonate, and (B) control prior to exposure. - The present invention has identified an oral composition unlike the oral compositions previously identified, capable of reducing or preventing dentinal hypersensitivity. It has been discovered by the present invention that an oral composition containing, and preferably consisting essentially of, arginine bicarbonate (or equivalents thereof) and calcium carbonate (or equivalents thereof) promotes the formation of dentinal tubule plugs aided by combining calcium and phosphate in the fluid. It has also been discovered by the present invention that an oral composition containing arginine bicarbonate and calcium carbonate promotes the formation of salivary precipitin, a carbohydrate-protein-calcium phosphate complex present primarily in dental plaque, which is formed from saliva when salivary proteins combine with calcium and phosphate, to reduce or prevent dentinal hypersensitivity.
- Arginine bicarbonate and calcium carbonate are the preferred components of compositions of the invention. However, compounds with equivalent or closely related properties can substitute for arginine bicarbonate. Other arginine compounds that can be used include, but are not limited to, arginine hydroxide, arginine carbonate, arginine phosphate, and arginine organic phosphate. Although arginine phytate may be used, preferably it is avoided except at high pH. Arginine bicarbonate is a guanidinium alkaline carbonate salt; other such salts may be used in its place. Examples include aminoguanidine and aminoguanidinium analogues.
- Also, calcium compounds with equivalent or closely related solubilities can substitute for calcium carbonate or part of it. These include monocalcium phosphate, dicalcium phosphate, tricalcium phosphate, calcium fluoride, calcium monofluorophosphate, sodium calcium pyrophosphate, calcium laurate, and calcium palmitate.
- Thus, the present invention relates to a method of reducing or preventing tooth hypersensitivity by delivering into the oral cavity an oral composition containing a therapeutically effective amount of arginine bicarbonate and calcium carbonate distributed in an oral vehicle. The amount of arginine bicarbonate and calcium carbonate sufficient to reduce or prevent dentinal hypersensitivity is an amount sufficient to promote dentinal plugging. It has been discovered that arginine bicarbonate and calcium carbonate promote the formation of and provide particles in the oral cavity for plugging the dentinal tubules of teeth. By plugging the dentinal tubules, the oral compositions used in the method of this invention are capable of reducing dentinal hypersensitivity. A mixture of arginine bicarbonate, which is highly soluble, with poorly soluble calcium carbonate (or calcium phosphate) yields a composition that gives a pH of about 8.0 to 9.0, which is ideal for tubule plugging. Calcium carbonate is a poorly soluble calcium salt which is defined here as one having a solubility of about 0.1 to about 100 mg in 100 ml of water at room temperature near or above a pH of about 5, and especially above neutral pH.
- Arginine bicarbonate and calcium carbonate are well suited for promoting dentinal plugging for a number of reasons. For one thing, they are effective neutralizers of acid especially since they can lose carbon dioxide and produce arginine hydroxide (arginine free base) and calcium hydroxide, respectively, when they come in contact with acid; this and being alkaline salts results in a rapid and substantial rise in the pH that is particularly favorable to deposit formation.
- A second reason is that calcium carbonate is poorly soluble above neutrality but is progressively more soluble as the pH becomes acidic. This behavior is similar to that of the calcium phosphate in tooth mineral tissues, thereby enabling the calcium carbonate to provide a renewable reservoir of calcium to reduce or prevent erosion of the cementum and dentine.
- A third reason is that arginine bicarbonate surprisingly has adhesive properties particularly useful at a pH ranging from about 7.5 to about 9.5, and preferably 8 to about 9 or 9.5. Together with the poor solubility of calcium carbonate or a like calcium salt, the arginine bicarbonate combination favors plugging of open dentinal tubules by binding of calcium carbonate particles and their attachment to the tubule walls and tooth surface. Demonstration of plugging effectiveness in an actual dentine plugging model shows the arginine bicarbonate/calcium carbonate combination is significantly superior. This means of plugging tubules is different from the prior art, where formation of tubule plugs is attempted by producing calcium phosphate precipitates from acidic solutions of moderately to highly soluble calcium and phosphate salt solutions or the like.
- Dentinal sensitivity resulting from the acids generated by bacteria is really an early stage in the development of a dental caries lesion. The bacteria found at the distal ends of tubules exposed to the oral environment are the same as those found in dental plaque.
- Consequently, the preferred bicarbonate cation is arginine since it will favor the base forming metabolism and the growth of arginolytic rather than non-arginolytic bacteria. The former are more alkalogenic and less cariogenic than the non-arginolytic bacteria. This additional factor will ensure sustenance of an elevated pH and a reservoir of alkali generation capability within and in association with the dentinal tubules.
- The preferred composition of arginine bicarbonate combined with calcium carbonate has a number of effects. It neutralizes any acid in the tubules, ensures a pH above neutrality and as high as, and in a specific embodiment greater than, about 9.0, provides needed calcium ions, provides a poorly soluble salt that has a small particle size to facilitate filling and plugging the dentinal tubules, and provides arginine to favor growth of and alkali production by alkalogenic bacteria for maintenance of an alkaline pH. Moreover and most importantly, arginine bicarbonate in the preferred pH range of use has been found unexpectedly to have adhesive properties that favor tubule plugging, an important property in light of the fact that in vivo flow of dentinal fluid out of the dentinal tubules under pressure makes any plugging difficult.
- As used herein, the terms “about” and “approximately” mean within 20%, preferably within 10%, and more preferably within 5% of a given value, unless another definition is provided.
- The present invention provides an oral composition containing therapeutic amounts of arginine bicarbonate and calcium carbonate distributed in an acceptable oral vehicle. The oral compositions of this invention by weight may contain, for example, arginine bicarbonate in a concentration ranging from about 1 to about 25% and calcium carbonate in a concentration ranging from about 5 to about 50%. In one embodiment, the oral composition further contains a therapeutically effective amount of fluoride, for example, 10 to 1500 ppm. Any conventional ingredients for the particular oral vehicle may further be added to the oral compositions of the present invention.
- The pH of the oral compositions of the present invention generally ranges from about 7.5 to about 9.5, preferably from about 8.0 to about 9.0, where arginine bicarbonate exhibits adhesive properties. The pH of the oral compositions described herein can be lowered with arginine bicarbonate or acid such as hydrochloric, or raised with arginine hydroxide (arginine free base) or bases such as sodium hydroxide or buffering agents such as sodium bicarbonate. In addition to arginine bicarbonate and calcium carbonate, the oral compositions of this invention may contain any conventional ingredient thr the particular oral vehicle discussed herein.
- The amount of calcium carbonate and arginine bicarbonate sufficient to reduce or prevent dentinal hypersensitivity varies with the type of oral vehicle used to deliver the therapeutic agent. Generally, the oral vehicles described by the present invention contain between approximately 5 grams to 50 grams of calcium carbonate and between approximately 1 gram to 25 grams of arginine bicarbonate per 100 grams oral composition. In a further embodiment of the present invention, the oral compositions used in the method of this invention contain a therapeutically effective amount of fluoride. The concentration of fluoride generally ranges from approximately 10 to 1500 ppm. Calcium fluoride is a preferred form of fluoride because it can be incorporated into a tubule plug along with calcium carbonate largely as particles, where fluoride ions along with calcium ions can be slowly released over prolonged periods of time. Despite its low solubility, calcium fluoride provides a source of calcium and fluoride ions and the ability to develop a less acid soluble tubule plug than if absent.
- Acceptable oral vehicles include any conventional oral delivery system, such as dental care products, food products, and chewing gum. Examples of dental care products include, for example, dentifrices, topical solutions or pastes, mouthwashes in the form of liquids or sprays or slurries, powders, gels or tablets, and dental flosses. Examples of food products which may contain oral compositions described herein include, for example, lozenges and confections.
- In addition to arginine bicarbonate and calcium carbonate, the oral compositions described in accordance with the present invention may contain any conventional ingredient for the particular oral vehicle. For example, liquid mouthwashes may contain solvents such as distilled or deionized water and ethanol; a sweetening agent such as saccharine, aspartame, sorbitol, mannitol, and xylitol; and a flavoring agent such as peppermint oil and spearmint oil (see U.S. Pat. Nos. 4,226,851 and 4,606,912). Dentifrices may contain, for example, a conventional abrasive such as resins, silica, and insoluble alkali metal metaphosphates in a standard amount of about 20% to about 60% by weight; a binder such as hydroxyethylcellulose, xanthin gum, and sodium carboxymethylcellulose in a standard amount ranging from about 0.5% to about 5.0% by weight; a foaming agent such as sodium lauryl sulfate, sodium coconut monoglyceride sulfonate, and sodium-N-methyl-N-palmitoyl taurine in a standard amount ranging from about 0.5% to about 3.0% by weight; a flavoring agent; a sweetening agent; an antiseptic agent and any other ingredient required for the particular composition as recognized by those skilled in the art (see U.S. Pat. Nos. 4,177,258 and 4,721,614). Tablets and powders may contain, for example, a vehicle such as lactose and mannitol, a binder such as corn starch and carboxymethylcellulose, and a disintegrator.
- A dentifrice or paste for localized application to a sensitive tooth site such as breeched cementum of an orally exposed root surface may be one that is simpler in composition and applied with a soft applicator. Such a dentifrice or paste may or may not contain conventional abrasive, foaming agent, and flavoring agents. Localized sites such as the dentine following tooth preparation for a dental restoration would also involve simpler compositions and include fillers used in dental pulp cappings, cavity liners and cements and any other ingredients required for the composition by those skilled in the art (Craig et al., 1989, Restorative Dental Materials. Mosby, St. Louis, pp. 189-225). For example, zinc oxide and eugenol at levels of (20 and 25%, respectively) would be appropriate for dental cement compositions.
- The oral compositions described herein be produced by adding arginine bicarbonate having a concentration by weight ranging from about 1 to about 25% and calcium carbonate having a concentration by weight ranging from about 5 to about 50% to an acceptable oral vehicle using conventional techniques. The pH of the composition may range from approximately 7.5 to approximately 9.5, preferably approximately 8.0 to approximately 9.0. The amount of arginine bicarbonate and calcium carbonate to retard or prevent dentinal hypersensitivity is an amount sufficient to plug the exposed dentinal tubules in teeth in the oral cavity by promoting the formation of dentinal plugs. For example, a dentifrice or paste may contain arginine bicarbonate and calcium carbonate in a concentration ranging from about 1 to about 25% and about 5 to about 50%, respectively. A mouthwash or slurry may also contain arginine bicarbonate and calcium carbonate in a concentration ranging from about 1 to about 25% and about 5 to about 50%, respectively.
- The present invention further provides an article of manufacture comprising a packaging material and the oral compositions described herein contained within said packaging material, wherein said oral composition is effective in retarding or preventing dentinal hypersensitivity and wherein said packaging material contains a label that indicates that said oral composition is effective in retarding or preventing dentinal hypersensitivity. The packaging material used to contain the oral compositions can comprise glass, plastic, metal or any other suitably inert material. For example, dentifrice containing the oral composition of the present invention may be contained in a collapsible tube, typically aluminum, line lead or plastic or a squeeze pump or pressurized dispenser to measure out the contents or in a tearable sachet.
- The oral composition of the present invention may also be used in a prophylaxis paste for polishing teeth or treating sensitive teeth or preventing the development of sensitive teeth after scaling, root planing or stain removal by a dentist or hygienist, in a small dental container, such as a tub of a size that permits easy access of the rotary attachments used in dental offices on dental hand-pieces.
- The present invention is directed to a method for promoting the formation of dentinal tubule plugs by delivering into the oral cavity an oral composition containing arginine bicarbonate and calcium carbonate. The present invention is further directed to a method for promoting the formation of salivary precipitin in the oral cavity by delivering into the oral cavity an oral composition containing arginine bicarbonate and calcium carbonate. In addition to arginine bicarbonate and calcium carbonate, the oral compositions used in this method may contain any conventional ingredient for the particular oral vehicle as outlined above. In another embodiment of this invention, the oral compositions used in this method contain a therapeutically effective amount of fluoride, generally between about 10 to about 1500 ppm. In one embodiment, the oral compositions contain arginine bicarbonate in an amount ranging from about 1 to about 25% and calcium carbonate in the amount ranging from about 5 to about 50%,
- In related applications, tubule plugging with arginine bicarbonate/calcium carbonate to stop dentinal fluid flow is desirable to enable proper placement of a non-leaking cavity liner, dental filling, or crown. Wetness, because of leakage of dentinal fluid, will often result in poor sealing of these devices or appliances. This is why sensitivity often persists and does so until natural tubule plugging or tooth pathology and demise occurs. Powder compositions of arginine bicarbonate/calcium carbonate provided in slurries or pastes are suitable for the formation of tubule plugs and use as a cavity lining material. Since dentinal fluid is derived from pulpal fluid, the arginine bicarbonate/calcium carbonate composition can provide the exposed pulp with a capping at the same time that adjacent open tubules are plugged.
- A related application is the calcification or mineralization of pits and fissures, which are sites where oral stimuli have access to underlying dentinal tubules because the enamel at their bases or sides is breeched as a result of tooth formation deficiencies or because of dental caries. Here, one can scoop or clean out the organic material in the pit or fissure with mechanical devices, and add arginine bicarbonate/calcium carbonate composition before placing a dental sealant or other filling thereon.
- Cavities deep enough to reach dentine exhibit sensitivity because they often involve open dentinal tubules. Inserting powder or paste compositions into carious lesions plugs these tubules and at the same time calcifies, hardens, and seals off difficult to remove carious material, a related application of this invention. Calcification of exposed tooth pulps can also be accomplished. Like dentinal fluid, pulp fluid (which is the source of dentinal fluid) contains calcium and phosphate so that it is amenable to calcification and sealing off the pulp from the oral environment. Once more, because of the alkaline pH and calcium provided, a slurry or paste containing arginine bicarbonate/calcium carbonate to an exposed pulp will suffice. This can also be placed into a pulp chamber from which pulp tissue has been removed.
- In order to further illustrate the present invention, the experiments described in the following examples were carried out. It should be understood that the invention is not limited to the specific examples or the details described therein.
- None of the prior art methods described above have used compositions that stimulate intrinsic blockage of the dentinal tubule. In this case, formation of a deposit uses tubule contents. Being a tissue fluid, dentinal fluid contains calcium and phosphate ions, which makes it amenable to calcification.
- In order to determine the conditions that promote intrinsic plug formation, we performed the following experiments. We prepared a solution comprised of the ions present in dentinal fluid (which acted as artificial dentinal fluid) and progressively added (titrated) various solutions thereto to determine the conditions and substances conducive to the formation of aggregates (i.e., dentinal plugs). Aggregation was determined by means of measurement of the absorbance with a spectrophotometer. From this, it was clear that at a pH of 8.5 and above, aggregation of dentinal fluid constituents occurred with arginine bicarbonate (
FIG. 1 ), and was enhanced by the addition of calcium carbonate (FIG. 2 ). Calcium carbonate by itself was not sufficient to produce deposit formation (FIG. 3 ), nor could one induce deposition by elevation of the pH as with addition of sodium hydroxide (FIG. 4 ) or sodium bicarbonate. Desirable precipitation was achieved by simultaneously raising the pH with highly soluble arginine bicarbonate and providing calcium from poorly soluble calcium carbonate (to supplement the calcium in dentinal tubule fluid), which calcium carbonate also acted as a filler material as described above to increase the ability to achieve tubule plugging. The 2 to 5 μm particle size of the calcium carbonate was small enough to easily enter the dentinal tubules and reduce the amount of precipitate needed to produce a stronger and more complete plug. - A composition of arginine bicarbonate, which is highly soluble, with poorly soluble calcium carbonate yielded a pH between about 8.5 and about 9.0, which is highly favorable for tubule plugging.
- A device developed by Greenhill and Pashley (J. Dental Research, 60:686-698, 1981) that enables simulation of dentinal tubule plugging in vivo was used to assess the effectiveness of the invention. Dentine discs that varied in thickness from 0.6 to 0.8 mm were cut with a Buhler Isomet saw from extracted caries-free molar teeth. They were then etched with 6% citric acid for two minutes to remove the smear layer and stored in 70% ethanol until used. A disc was mounted in the chamber of the apparatus with occlusal side facing upwards. The occlusal side is determined by passing light through a plastic grid beneath the section and observing the section with a dissecting microscope. The tubules appear further apart with the occlusal side up because of the lower tubular density of the dentine occlusally (Walton et al., J. Dental Research 55:639-642, 1976). Hydraulic conductance of fluid through the discs was determined as described by Greenhill and Pashley, supra.
- Fluid containing levels of ions present in serum (Merck Manual, 1972) was used to perfuse the disc. Their concentrations in mM were as follows: Na—140.5, K—4.31, Ca—2.5, Mg—1.0, P—1.3. The pH of this solution is raised to 7.0 with sodium hydroxide. The solution was filtered through a 0.22 mm filter (Millipore Corp., Marlborough, Mass. 01752) prior to use to remove any bacteria present. This solution is called artificial ionic dentinal fluid (AIDF). Hydrostatic pressure was created by a fluid reservoir leading via a glass capillary tube into the pulpal side of the chamber at a level 30 cm above that of the surface of the horizontally positioned disc. The distance traveled by an air bubble positioned in the AIDF in the capillary tubing between this pressure head and the pulpal side of the disc in a fixed period of time was converted to hydraulic conductance values in ml cm−1 min−1 cm H20−1.
- Sections were exposed to an arginine bicarbonate/calcium carbonate mixture and various controls as follows. First, 400 ml of AIDF was applied to the upward facing occlusal side of the section and AIDF was allowed to flow through the disc from the pulpal side for a period of five minutes. The distance that the air bubble moved inside the capillary on the pulpal side of the chamber was measured so that the rate of fluid movement through the disc could be calculated and converted to hydraulic conductance values. This procedure was repeated two more times or until a uniform flow rate was achieved on three consecutive runs. The AIDF was then replaced by 400 μl of a 1:4 arginine bicarbonate/calcium carbonate slurry and brushed on the dentine surface for two minutes. Next, the mixture was removed with a pipette, washed three times with 400 μl of deionized water and replaced with AIDF. The AIDF was allowed to flow through the dentine slice and hydraulic conductance readings were made at selected times up to 90 minutes.
- New dentin sections were selected and the experiment repeated using either (i) sodium bicarbonate plus calcium carbonate in the same ratio as the arginine bicarbonate/calcium carbonate mixture, (ii) arginine bicarbonate alone, (iii) sodium bicarbonate (iv) calcium carbonate alone, or (v) distilled water.
- Table 1 shows the results. The hydraulic conductance fell the most with the arginine bicarbonate/calcium carbonate mixture. Calcium carbonate, arginine bicarbonate, distilled water and combining sodium bicarbonate and calcium carbonate had much smaller effects, in some cases, a negative result (i.e. an increase in conductance) was seen. Examination of the discs by scanning electron microscopy revealed substantial blockage of the orifices of the dentinal tubules with the arginine bicarbonate/calcium carbonate mixture but little or no blockage with the other test substances shown in the table. Blockage of dentinal tubules is considered central to reduction of dentinal hypersensitivity.
-
TABLE 1 Percent Reduction in Hydraulic Conductance Minutes after exposure Test Compounds 0 15 30 45 60 75 90 arginine bicarbonate + 0 13.7 23.3 28.1 30.8 34.9 35.6 calcium carbonate sodium bicarbonate + 0 −36.1 −27.8 −31.3 −34.0 −31.3 −28.5 calcium carbonate arginine bicarbonate 0 11.7 15.6 14.4 14.5 16.1 16.1 sodium bicarbonate 0 −10.6 −1.0 7.2 11.5 15.9 19.7 calcium carbonate 0 −18.5 −12.3 −5.5 −4.1 5.5 5.5 water 0 2.0 1.0 5.6 8.1 8.1 8.1 - Arginine bicarbonate has adhesive properties desirable for plugging dentinal tubules. Arginine bicarbonate is prepared from arginine (free base) by titrating the arginine with gaseous carbon dioxide as follows. 7.5 g of arginine is dissolved in 50 ml of deionized water and has a pH of about 10.6. Then carbon dioxide is delivered thereto under pressure (2 lbs./sq. in.) from a commercial gas cylinder until a solution pH of 7.2 is reached. This is the pH at which the carbon dioxide has converted all or most of the arginine to arginine bicarbonate. For intrinsic plugging and the formation of salivary precipitin, a pH between 8 and 9 is preferred. This is done by titrating the arginine with carbon dioxide to a desired pH between 8 and 9 or by mixing of the arginine bicarbonate with the more alkaline arginine free base to a desired pH between 8 and 9. The adhesive properties of arginine bicarbonate are retained as well as the ability to produce intrinsic plugging and promotion of salivary precipitin formation.
- Scanning electron micrographs show the ability of arginine bicarbonate plus calcium carbonate to plug open dentinal tubules (
FIG. 5A ) compared to calcium carbonate alone (FIG. 6A ) and arginine bicarbonate alone (FIG. 7A ). Control samples (FIGS. 5B , 6B, 7B) were photographed prior to exposure to arginine bicarbonate plus calcium carbonate or either compound alone. Thus, although calcium carbonate is a poorly soluble calcium salt, its small particle size and interaction with arginine bicarbonate make the combination suitable for plugging open dentinal tubules. - The present invention is not to be limited in scope by the specific embodiments described herein. Indeed, various modifications of the invention in addition to those described herein will become apparent to those skilled in the art from the foregoing description and the accompanying figures. Such modifications are intended to fall within the scope of the appended claims.
- All patents, patent applications, publications, and other materials cited herein are hereby incorporated herein reference in their entireties.
Claims (46)
1. A prophypaste comprising a guanidinium alkaline salt or free base, a calcium salt which is poorly soluble in water, and an orally acceptable carrier, wherein the pH of the prophypaste ranges from about 7.5 to about 9.5.
2. The prophypaste of claim 1 , wherein the guanidinium is arginine.
3. The prophypaste of claim 2 , wherein the arginine salt is selected from the group consisting of arginine bicarbonate, arginine hydroxide, arginine carbonate, arginine phosphate, and arginine organic phosphate.
4. The prophypaste of claim 1 , wherein the solubility of the calcium salt is between about 0.1 and about 100 mg in 100 ml of water near and about room temperature and near and above pH of about 5.
5. The prophypaste of claim 1 , wherein the calcium salt is selected from the group consisting of calcium carbonate, monocalcium phosphate, dicalcium phosphate, tricalcium phosphate, calcium fluoride, calcium monofluorophosphate, sodium calcium pyrophosphate, calcium laurate, calcium palmitate, and combinations thereof.
6. The prophypaste of claim 1 , further comprising a protein denaturing agent.
7. A dental container comprising a packaging material and the prophypaste of claim 1 , wherein the prophypaste is effective in retarding or preventing dentinal hypersensitivity.
8. The dental container of claim 7 , wherein the dental Container is of a size that permits easy access of the rotary attachments used in dental offices on dental hand-pieces.
9. A method of treating or preventing dentinal sensitivity in a tooth, which method comprises applying the prophypaste of claim 1 , wherein a pH of the prophypaste ranges from about 7.5 to about 9.5, to tooth surfaces exposed by gingival recession or tooth areas that have a deficiency or have experienced loss of enamel or cementum.
10. A method of plugging tubules, which method comprises administering the prophypaste of claim 1 , wherein a pH of the prophypaste ranges from about 7.5 to about 9.5, to a tooth where tubule plugging is desired.
11. A method of treating a carious lesion, which method comprises administering the prophypaste of claim 1 , wherein a pH of the prophypaste ranges from about 7.5 to about 9.5, to the carious lesion.
12. A method of calcifying an exposed tooth pulp, which method comprises administering the prophypaste of claim 1 , wherein a pH of the prophypaste ranges from about 7.5 to about 9.5, to the exposed tooth pulp.
13. A dental floss impregnated with a composition comprising a guanidinium alkaline salt or free base, a calcium salt which is poorly soluble in water, and an orally acceptable carrier, wherein the pH of the composition ranges from about 7.5 to about 9.5.
14. The dental floss of claim 13 , wherein the guanidinium is arginine.
15. The dental floss of claim 14 , wherein the arginine salt is arginine bicarbonate, arginine hydroxide, arginine carbonate, arginine phosphate, and arginine organic phosphate.
16. The dental floss of claim 13 , wherein the calcium salt is selected from the group consisting of calcium carbonate, monocalcium phosphate, dicalcium phosphate, dicalcium phosphate, tricalcium phosphate, calcium fluoride, calcium monofluorophosphate, sodium calcium pyrophosphate, calcium laurate, calcium palmitate, and combinations thereof.
17. A method of treating or preventing dentinal sensitivity in a tooth, which method comprises applying the dental floss of claim 13 to tooth surfaces exposed by gingival recession or tooth areas that have experienced loss of enamel or cementum.
18. A food product comprising a guanidinium alkaline salt or free base, a calcium salt which is poorly soluble in water, and an orally acceptable carrier, wherein the of the food product ranges from about 7.5 to about 9.5.
19. The food product of claim 18 , wherein the guanidinium is arginine.
20. The food product of claim 19 , wherein the arginine salt is arginine bicarbonate, arginine hydroxide, arginine carbonate, arginine phosphate, and arginine organic phosphate.
21. The food product of claim 18 , wherein the calcium salt is selected from the group consisting of calcium carbonate, monocalcium phosphate, dicalcium phosphate, tricalcium phosphate, calcium fluoride, calcium monofluorophosphate, sodium calcium pyrophosphate, calcium laurate, calcium palmitate and combinations thereof.
22. The food product of claim 18 , further comprising a sweetening agent.
23. The food product of claim 22 , wherein the sweetening agent is selected from the group consisting of saccharine, aspartame, sorbitol, mannitol, and xylitol.
24. The food product of claim 18 , wherein the guanidinium is arginine bicarbonate and the calcium salt is calcium carbonate.
25. A method of treating or preventing dentinal sensitivity in a tooth, which method comprises applying the food product of claim 18 to tooth surfaces exposed by gingival recession or tooth areas that have a deficiency or have experienced loss of enamel or cementum.
26. A method of calcifying the base or all of a pit or fissure in a tooth, which method comprises administering the food product of claim 18 into the pits and fissures.
27. A gum comprising a guanidinium alkaline salt or free base, a calcium salt which is poorly soluble in water, and an orally acceptable carrier, wherein the pH of the gum ranges from about 7.5 to about 9.5.
28. The gum of claim 27 , wherein the guanidinium is arginine.
29. The gum of claim 28 , wherein the arginine salt is arginine bicarbonate, arginine hydroxide, arginine carbonate, arginine phosphate, and arginine organic phosphate.
30. The gum of claim 27 wherein the calcium salt is selected from the group consisting of calcium carbonate, monocalcium phosphate, dicalcium phosphate, tricalcium phosphate, and combinations thereof.
31. The gum of claim 27 , wherein the guanidinium is arginine bicarbonate and the calcium salt is selected from the group consisting of calcium carbonate, calcium phosphate, and combinations thereof.
32. A method of treating or preventing dentinal sensitivity in a tooth, which method comprises administering the gum of claim 27 to tooth surfaces exposed by gingival recession or tooth areas that have a deficiency or have experienced loss of enamel or cementum.
33. A method of calcifying the base or all of a pit or fissure in a tooth, which method comprises administering the gum of claim 27 into the pits and fissures.
34. A confection comprising a guanidinium alkaline salt or free base, a calcium salt which is poorly soluble in water, and an orally acceptable carrier, wherein the pH of the composition ranges from about 7.5 to about 9.5.
35. The confection of claim 34 , wherein the guanidinium is arginine.
36. The confection of claim 35 , wherein the arginine salt is arginine bicarbonate, arginine hydroxide, arginine carbonate, arginine phosphate, and arginine organic phosphate.
37. The confection of claim 34 , wherein the calcium salt is selected from the group consisting of calcium carbonate, monocalcium phosphate, dicalcium phosphate, tricalcium phosphate, and combinations thereof.
38. The confection of claim 34 , wherein the guanidinium is arginine bicarbonate and the calcium salt is selected from the group consisting of calcium carbonate, calcium phosphate, and combinations thereof.
39. A method of treating or preventing dentinal sensitivity in a tooth, which method comprises applying the confection of claim 34 to tooth surfaces exposed by gingival recession or tooth areas that have a deficiency or have experienced loss of enamel or cementum.
40. A method of calcifying the base or all of a pit or fissure in a tooth, which method comprises administering the confection of claim 34 into the pits and fissures.
41. A dental care product impregnated with a composition comprising a guanidinium alkaline salt or free base, a calcium salt which is poorly soluble in water, and an orally acceptable carrier, wherein the pH of the composition ranges from about 7.5 to about 9.5.
42. The dental care product of claim 41 , wherein the guanidinium is arginine.
43. The dental care product of claim 42 , wherein the arginine salt is arginine bicarbonate, arginine hydroxide, arginine carbonate, arginine phosphate, and arginine organic phosphate.
44. The dental care product of claim 41 , wherein the calcium salt is selected from the group consisting of calcium carbonate, monocalcium phosphate, dicalcium phosphate, tricalcium phosphate, and combinations thereof.
45. A method of treating or preventing dentinal sensitivity in a tooth, which method comprises applying the dental care product of claim 41 to tooth surfaces exposed by gingival recession or tooth areas that have a deficiency or have experienced loss of enamel or cementum.
46. A method of calcifying the base or all of a pit or fissure in a tooth, which method comprises administering the dental care product of claim 41 into the pits and fissures.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/250,412 US20120027828A1 (en) | 1999-06-23 | 2011-09-30 | Dental anti-hypersensitivity composition and method |
US14/034,268 US20140120142A1 (en) | 1999-06-23 | 2013-09-23 | Dental Anti-Hypersensitivity Composition and Method |
US15/066,994 US20160279042A1 (en) | 1999-06-23 | 2016-03-10 | Dental Anti-Hypersensitivity Composition and Method |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14056099P | 1999-06-23 | 1999-06-23 | |
US09/504,264 US6436370B1 (en) | 1999-06-23 | 2000-02-15 | Dental anti-hypersensitivity composition and method |
US09/940,723 US6524558B2 (en) | 1999-06-23 | 2001-08-27 | Dental anti-hypersensitivity composition and method |
US10/328,389 US20030133885A1 (en) | 1999-06-23 | 2002-12-23 | Dental anti-hypersensitivity composition and method |
US11/836,041 US20080233054A1 (en) | 1999-06-23 | 2007-08-08 | Dental anti-hypersensitivity composition and method |
US13/250,412 US20120027828A1 (en) | 1999-06-23 | 2011-09-30 | Dental anti-hypersensitivity composition and method |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/836,041 Continuation US20080233054A1 (en) | 1999-06-23 | 2007-08-08 | Dental anti-hypersensitivity composition and method |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/034,268 Division US20140120142A1 (en) | 1999-06-23 | 2013-09-23 | Dental Anti-Hypersensitivity Composition and Method |
Publications (1)
Publication Number | Publication Date |
---|---|
US20120027828A1 true US20120027828A1 (en) | 2012-02-02 |
Family
ID=22491802
Family Applications (7)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/504,264 Expired - Lifetime US6436370B1 (en) | 1999-06-23 | 2000-02-15 | Dental anti-hypersensitivity composition and method |
US09/940,723 Expired - Lifetime US6524558B2 (en) | 1999-06-23 | 2001-08-27 | Dental anti-hypersensitivity composition and method |
US10/328,389 Abandoned US20030133885A1 (en) | 1999-06-23 | 2002-12-23 | Dental anti-hypersensitivity composition and method |
US11/836,041 Abandoned US20080233054A1 (en) | 1999-06-23 | 2007-08-08 | Dental anti-hypersensitivity composition and method |
US13/250,412 Abandoned US20120027828A1 (en) | 1999-06-23 | 2011-09-30 | Dental anti-hypersensitivity composition and method |
US14/034,268 Abandoned US20140120142A1 (en) | 1999-06-23 | 2013-09-23 | Dental Anti-Hypersensitivity Composition and Method |
US15/066,994 Abandoned US20160279042A1 (en) | 1999-06-23 | 2016-03-10 | Dental Anti-Hypersensitivity Composition and Method |
Family Applications Before (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US09/504,264 Expired - Lifetime US6436370B1 (en) | 1999-06-23 | 2000-02-15 | Dental anti-hypersensitivity composition and method |
US09/940,723 Expired - Lifetime US6524558B2 (en) | 1999-06-23 | 2001-08-27 | Dental anti-hypersensitivity composition and method |
US10/328,389 Abandoned US20030133885A1 (en) | 1999-06-23 | 2002-12-23 | Dental anti-hypersensitivity composition and method |
US11/836,041 Abandoned US20080233054A1 (en) | 1999-06-23 | 2007-08-08 | Dental anti-hypersensitivity composition and method |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/034,268 Abandoned US20140120142A1 (en) | 1999-06-23 | 2013-09-23 | Dental Anti-Hypersensitivity Composition and Method |
US15/066,994 Abandoned US20160279042A1 (en) | 1999-06-23 | 2016-03-10 | Dental Anti-Hypersensitivity Composition and Method |
Country Status (11)
Country | Link |
---|---|
US (7) | US6436370B1 (en) |
EP (1) | EP1187593B1 (en) |
AT (1) | ATE365526T1 (en) |
AU (1) | AU5890800A (en) |
CA (1) | CA2377598C (en) |
CY (1) | CY1108058T1 (en) |
DE (1) | DE60035344T2 (en) |
DK (1) | DK1187593T3 (en) |
ES (1) | ES2288862T3 (en) |
PT (1) | PT1187593E (en) |
WO (1) | WO2000078270A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015067422A1 (en) * | 2013-11-07 | 2015-05-14 | Unilever Plc | Compositions and methods for treating tooth hypersensitivity |
US9717665B2 (en) | 2013-10-28 | 2017-08-01 | The Procter & Gamble Company | Tooth desensitizing oral care compositions, devices, and methods |
US9927422B2 (en) | 2014-05-13 | 2018-03-27 | The Procter & Gamble Company | Method and device for measuring dentin permeability |
Families Citing this family (86)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2584508A1 (en) | 2002-05-09 | 2003-11-09 | Institut National De La Recherche Scientifique | Method for producing single-wall carbon nanotubes |
US20040101493A1 (en) * | 2002-11-26 | 2004-05-27 | Scott Douglas Craig | Chewable solid unit dosage forms and methods for delivery of active agents into occlusal surfaces of teeth |
BRPI0300644B8 (en) | 2003-02-20 | 2022-04-26 | Fundacao Univ Federal De Sao Carlos | Process of preparing particulate, bioactive and resorbable biosilicates, compositions for preparing said biosilicates and bioactive and resorbable particulate biosilicates. |
WO2005016368A2 (en) * | 2003-08-19 | 2005-02-24 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Use of phosphophoryn for inducing biomineralization and bone regeneration |
US20070054243A1 (en) * | 2005-09-07 | 2007-03-08 | Jurgen Schemmer | Method and apparatus for treating dentin sensitivity |
CN102358746A (en) * | 2005-12-16 | 2012-02-22 | 戴维·坎纳尔 | Surface active calcium phosphates |
US20080274065A1 (en) * | 2006-05-09 | 2008-11-06 | Richard Scott Robinson | Oral Care Regimen |
CN103860390A (en) | 2006-05-09 | 2014-06-18 | 高露洁-棕榄公司 | Oral care regimen |
US20090155318A1 (en) * | 2006-10-31 | 2009-06-18 | Lee Howard W H | Process to form nano-sized materials, the compositions and uses thereof |
US20080267891A1 (en) * | 2007-04-30 | 2008-10-30 | Colgate-Palmolive Company | Oral Care Composition To Reduce Or Eliminate Dental Sensitivity |
EP2070422A1 (en) * | 2007-12-05 | 2009-06-17 | Südzucker Aktiengesellschaft Mannheim/Ochsenfurt | Confectionery products promoting dental health |
RU2477122C2 (en) * | 2008-02-08 | 2013-03-10 | Колгейт-Палмолив Компани | Compositions and methods with using peptides containing basic amino acids and proteases |
AU2012211481B2 (en) * | 2008-02-08 | 2013-08-22 | Colgate-Palmolive Company | Arginine salts and their uses for the treatment of illnesses in the oral cavity |
AU2013200182B2 (en) * | 2008-02-08 | 2015-05-21 | Colgate-Palmolive Company | Oral care product and methods of use and manufacture thereof |
WO2009100269A2 (en) | 2008-02-08 | 2009-08-13 | Colgate-Palmolive Company | Oral care product and methods of use and manufacture thereof |
AR070589A1 (en) * | 2008-02-08 | 2010-04-21 | Colgate Palmolive Co | SEALANT FOR TEETH |
US10130597B2 (en) * | 2008-02-08 | 2018-11-20 | Colgate-Palmolive Company | Compositions and devices |
US10471283B2 (en) * | 2008-02-08 | 2019-11-12 | Colgate-Palmolive Company | Compositions and methods for the treatment of xerostomia |
US20110052509A1 (en) * | 2008-02-08 | 2011-03-03 | Colgate-Palmolive Company | Compositions comprising basic amino acid and soluble carbonate salt |
AU2012204031B2 (en) * | 2008-02-08 | 2013-09-05 | Colgate-Palmolive Company | Oral care product and methods of use and manufacture thereof |
EP3100716B1 (en) * | 2008-02-08 | 2018-09-26 | Colgate-Palmolive Company | Novel salts and their uses |
AU2009212337B2 (en) * | 2008-02-08 | 2012-01-12 | Colgate-Palmolive Company | Cleaning compositions and methods |
WO2009100272A2 (en) * | 2008-02-08 | 2009-08-13 | Colgate-Palmolive Company | Effervescent compositions |
EP2249787B1 (en) * | 2008-02-08 | 2017-07-19 | Colgate-Palmolive Company | Oral care product and methods of use and manufacture thereof |
AU2015215853B2 (en) * | 2008-02-08 | 2016-11-03 | Colgate-Palmolive Company | Oral care product and methods of use and manufacture thereof |
CA2707086C (en) * | 2008-02-08 | 2014-10-21 | Colgate-Palmolive Company | Oral care toothbrush with reservoir to dispense oral care composition |
WO2009100276A2 (en) | 2008-02-08 | 2009-08-13 | Colgate-Palmolive Company | Dental floss |
US8399704B2 (en) * | 2008-02-08 | 2013-03-19 | Colgate-Palmolive Company | Methods for salt production |
MX364537B (en) * | 2008-02-08 | 2019-04-30 | Colgate Palmolive Co | Oral care product and methods of use and manufacture thereof. |
EP2249783B1 (en) | 2008-02-08 | 2021-04-07 | Colgate-Palmolive Company | Oral care product and methods of use thereof |
US20090202452A1 (en) * | 2008-02-08 | 2009-08-13 | Colgate-Palmolive Company | Oral care regimen |
EP2249791A4 (en) * | 2008-02-08 | 2014-01-08 | Colgate Palmolive Co | Compositions and devices |
JP2011511796A (en) * | 2008-02-08 | 2011-04-14 | コルゲート・パーモリブ・カンパニー | Dental wipe |
BRPI0821857A2 (en) * | 2008-02-08 | 2014-09-30 | Colgate Palmolive Co | MAINTENANCE COMPOSITION FOR PERIODIC ORAL CARE, COMBINED PREPARATION, USES OF A BASIC AMINO ACID IN THE FREE OR SALT FORM, PERIODIC ORAL CARE MAINTENANCE COMPOSITION AND A COMPOSITION FOR PRIMARY ORAL CARE AND COMPOSITION OR PREPARATION |
AU2009212319B2 (en) * | 2008-02-08 | 2012-11-15 | Colgate-Palmolive Company | Oral care product and methods of use and manufacture thereof |
CN102037360B (en) | 2008-02-08 | 2016-10-05 | 高露洁-棕榄公司 | oral care method and system |
JP5584629B2 (en) * | 2008-02-08 | 2014-09-03 | コルゲート・パーモリブ・カンパニー | Two component oral care products |
US20100047742A1 (en) * | 2008-08-25 | 2010-02-25 | Pitcock Jr William Henry | Tubule-blocking silica materials for dentifrices |
US20090005320A1 (en) * | 2008-09-02 | 2009-01-01 | Bruce Kneller | Compositions comprising amino acid bicarbonate and methods of use thereof |
TWI395595B (en) * | 2009-04-01 | 2013-05-11 | Colgate Palmolive Co | Oral compositions for treating tooth sensitivity and methods of use and manufacture thereof |
RU2505280C2 (en) * | 2009-05-18 | 2014-01-27 | Колгейт-Палмолив Компани | Oral compositions containing polyguanidine compounds, and methods for preparing and using them |
TWI499430B (en) | 2009-12-17 | 2015-09-11 | Colgate Palmolive Co | Anti-erosion toothpaste composition |
WO2011075472A1 (en) * | 2009-12-18 | 2011-06-23 | Colgate-Palmolive Company | Methods for production of arginine bicarbonate at low pressure |
WO2011075422A1 (en) * | 2009-12-18 | 2011-06-23 | Colgate-Palmolive Company | Methods for production of high concentration of arginine bicarbonate solution at high pressue |
MX360382B (en) | 2009-12-29 | 2018-10-31 | Grace W R & Co | Compositions for forming obscuration films and methods of making and using the same. |
WO2011094499A2 (en) | 2010-01-29 | 2011-08-04 | Colgate-Palmolive Company | Oral care product for sensitive enamel care |
US20110206749A1 (en) * | 2010-02-19 | 2011-08-25 | J.M. Huber Corporation | Silica materials for reducing oral malador |
US8658139B1 (en) | 2010-02-27 | 2014-02-25 | Squigle, Inc. | Prevention and treatment of oral diseases |
US20110236444A1 (en) * | 2010-03-25 | 2011-09-29 | Darsillo Michael S | Antimicrobial Silica Composites |
SG185631A1 (en) * | 2010-06-23 | 2012-12-28 | Colgate Palmolive Co | Therapeutic oral composition |
WO2012023936A1 (en) * | 2010-08-18 | 2012-02-23 | Colgate-Palmolive Company | Oral care product and methods of use and manufacture thereof |
BR112013003526B8 (en) * | 2010-09-10 | 2018-02-27 | Unilever Nv | "oral care composition, packaged product and method for making mouth improvements" |
CN107308010A (en) | 2010-09-10 | 2017-11-03 | 荷兰联合利华有限公司 | Composite particles active matter and its manufacture method |
EP2626058B1 (en) | 2010-10-06 | 2019-05-01 | Kuraray Noritake Dental Inc. | Dentinal tubule sealant and method for producing the same |
US9717929B2 (en) | 2010-12-07 | 2017-08-01 | Colgate-Palmolive Company | Dentifrice compositions containing calcium silicate and a basic amino acid |
US9320690B2 (en) | 2010-12-20 | 2016-04-26 | Colgate-Palmolive Company | Gelatin encapsulated oral care composition containing hydrophilic active, hydrophobic structuring agent and oil carrier |
RU2556857C2 (en) | 2010-12-20 | 2015-07-20 | Колгейт-Палмолив Компани | Incapsulated in gelatine composition for oral cavity care, containing active substances for dental occlusion, hydrophobic modifier of viscosity and oily carrier |
CN107088168A (en) | 2010-12-20 | 2017-08-25 | 高露洁-棕榄公司 | Include the non-aqueous oral care composition of tooth closing activity thing |
US9724277B2 (en) * | 2011-04-04 | 2017-08-08 | Robert L. Karlinsey | Microbeads for dental use |
US20140248322A1 (en) * | 2011-04-04 | 2014-09-04 | Robert L. Karlinsey | Dental compositions containing silica microbeads |
BR112014004760B8 (en) * | 2011-09-08 | 2019-01-02 | Unilever Nv | toothpaste composition, remineralization and / or teeth whitening method |
RU2467739C1 (en) * | 2011-10-31 | 2012-11-27 | Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" | Dental formulation for treating dental hyperesthesia |
DE102011056142A1 (en) * | 2011-12-07 | 2013-06-13 | Manfred Rüdinger | Metabolizable salts and their use in diagnostics and therapy |
AU2011383635B2 (en) | 2011-12-21 | 2014-10-23 | Colgate-Palmolive Company | Oral care compositions |
BR112015002531B1 (en) * | 2012-08-09 | 2020-02-27 | Unilever N.V. | COMPOSITION, AND USE OF A COMPOSITION |
BR112015002551B1 (en) * | 2012-08-09 | 2019-10-15 | Unilever N.V. | COMPOSITION AND USE OF COMPOSITION |
KR20150090130A (en) * | 2012-12-03 | 2015-08-05 | 콜게이트-파아므올리브캄파니 | Oral care compositions comprising calcium carbonate and a preservative system based on benzyl alcohol or benzoic acid, and an alkylene glycol |
AU2013353580B2 (en) | 2012-12-06 | 2015-08-20 | Colgate-Palmolive Company | Oral gel for sensitivity and tooth pain |
IN2015DN03993A (en) * | 2012-12-06 | 2015-10-02 | Colgate Palmolive Co | |
DE102013004088A1 (en) | 2013-03-11 | 2014-09-11 | Voco Gmbh | Particularly storage-stable and thixotropic stable prophylaxis paste for professional dental use |
WO2014185884A1 (en) * | 2013-05-13 | 2014-11-20 | Colgate-Palmolive Company | Oral care composition containing pumice and calcium carbonate |
WO2015019600A1 (en) * | 2013-08-06 | 2015-02-12 | クラレノリタケデンタル株式会社 | Curable calcium phosphate composition for in vivo hard tissue repair, bone repair material, and various dental materials |
JP6333821B2 (en) * | 2013-08-06 | 2018-05-30 | クラレノリタケデンタル株式会社 | Ivory tubule sealant |
ITMI20132003A1 (en) * | 2013-11-29 | 2015-05-30 | Perfetti Van Melle Spa | CONFETTER PRODUCTS WITH CALCIUM PHOSPHATE |
WO2015084321A1 (en) | 2013-12-03 | 2015-06-11 | Colgate-Palmolive Company | Oral care compositions |
EP2921173A1 (en) * | 2014-03-21 | 2015-09-23 | Omya International AG | Surface-reacted calcium carbonate for desensitizing teeth |
EP2959884A1 (en) * | 2014-06-24 | 2015-12-30 | Pamela Fialka | New composition for remineralizing teeth |
BR112017012636B1 (en) | 2014-12-23 | 2021-01-19 | Colgate-Palmolive Company | oral care composition and use of free or salt basic amino acid, calcium carbonate, a source of fluoride ions and a flavoring agent comprising less than 50% menthol and an anionic surfactant |
WO2017079953A1 (en) | 2015-11-13 | 2017-05-18 | The Procter & Gamble Company | Dentifrice compositions with improved fluoride stability |
WO2017079956A1 (en) | 2015-11-13 | 2017-05-18 | The Procter & Gamble Company | Dentifrice compositions with dual fluoride source with improved fluoride uptake |
WO2017079957A1 (en) * | 2015-11-13 | 2017-05-18 | The Procter & Gamble Company | Dentifrice compositions with improved fluoride uptake |
US11033096B2 (en) * | 2017-12-12 | 2021-06-15 | Colgate-Palmolive Company | Oral care refill head and oral care kit including the same |
AU2018448003B2 (en) * | 2018-11-02 | 2021-09-23 | Colgate-Palmolive Company | Oral care compositions comprising N-alkyl-N-acylglucamines |
US10736830B2 (en) | 2018-11-02 | 2020-08-11 | Colgate-Palmolive Company | Oral care compositions and methods for the same |
RU2741992C2 (en) * | 2019-04-12 | 2021-02-01 | Колгейт-Палмолив Компани | Oral care composition eliminating unpleasant odor |
WO2021051151A1 (en) * | 2019-09-16 | 2021-03-25 | Yndk Pty. Ltd. | Oral health improving products |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3228845A (en) * | 1963-02-28 | 1966-01-11 | William K Najjar | Dental cleanser paste |
US5762911A (en) * | 1996-03-05 | 1998-06-09 | The Research Foundation Of State University Of New York | Anti-caries oral compositions |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3943241A (en) | 1971-08-30 | 1976-03-09 | General Mills, Inc. | Cariostatic composition |
US3932608A (en) | 1971-08-30 | 1976-01-13 | General Mills, Inc. | Food composition |
US3826004A (en) * | 1972-04-17 | 1974-07-30 | J Graceffo | Dental prophylaxis instrument |
US4139599A (en) * | 1973-01-11 | 1979-02-13 | Colgate Palmolive Company | Process for preparing dicalcium phosphate dihydrate having a portion of the calcium displaced by divalent metal ion |
US4064138A (en) | 1975-11-12 | 1977-12-20 | General Mills, Inc. | Amino acid derivatives |
ZA773318B (en) * | 1976-06-18 | 1978-04-26 | I Kleinberg | Means and method for improving natural defenses against caries |
GB1573727A (en) * | 1978-05-19 | 1980-08-28 | Colgate Palmolive Co | Dentifrices |
JPS5835965B2 (en) * | 1979-07-31 | 1983-08-05 | ライオン株式会社 | Oral composition |
JPS61233612A (en) | 1985-04-10 | 1986-10-17 | Kao Corp | Chewing gum |
US5370865A (en) | 1992-05-15 | 1994-12-06 | Kao Corporation | Composition for use in oral cavity |
JP3566374B2 (en) * | 1994-02-03 | 2004-09-15 | 花王株式会社 | Oral composition |
EP0711543B1 (en) | 1994-11-11 | 2003-02-19 | Unilever Plc | Oral preparations |
HUP0100090A3 (en) * | 1997-12-18 | 2002-11-28 | Unilever Nv | Oral care composition |
US6200550B1 (en) * | 1998-12-11 | 2001-03-13 | Q-Pharma, Inc. | Oral care compositions comprising coenzyme Q10 |
-
2000
- 2000-02-15 US US09/504,264 patent/US6436370B1/en not_active Expired - Lifetime
- 2000-06-23 DE DE60035344T patent/DE60035344T2/en not_active Expired - Lifetime
- 2000-06-23 CA CA2377598A patent/CA2377598C/en not_active Expired - Lifetime
- 2000-06-23 ES ES00944881T patent/ES2288862T3/en not_active Expired - Lifetime
- 2000-06-23 EP EP00944881A patent/EP1187593B1/en not_active Expired - Lifetime
- 2000-06-23 WO PCT/US2000/017518 patent/WO2000078270A1/en active IP Right Grant
- 2000-06-23 AT AT00944881T patent/ATE365526T1/en active
- 2000-06-23 AU AU58908/00A patent/AU5890800A/en not_active Abandoned
- 2000-06-23 DK DK00944881T patent/DK1187593T3/en active
- 2000-06-23 PT PT00944881T patent/PT1187593E/en unknown
-
2001
- 2001-08-27 US US09/940,723 patent/US6524558B2/en not_active Expired - Lifetime
-
2002
- 2002-12-23 US US10/328,389 patent/US20030133885A1/en not_active Abandoned
-
2007
- 2007-08-08 US US11/836,041 patent/US20080233054A1/en not_active Abandoned
- 2007-09-17 CY CY20071101194T patent/CY1108058T1/en unknown
-
2011
- 2011-09-30 US US13/250,412 patent/US20120027828A1/en not_active Abandoned
-
2013
- 2013-09-23 US US14/034,268 patent/US20140120142A1/en not_active Abandoned
-
2016
- 2016-03-10 US US15/066,994 patent/US20160279042A1/en not_active Abandoned
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3228845A (en) * | 1963-02-28 | 1966-01-11 | William K Najjar | Dental cleanser paste |
US5762911A (en) * | 1996-03-05 | 1998-06-09 | The Research Foundation Of State University Of New York | Anti-caries oral compositions |
Non-Patent Citations (2)
Title |
---|
British Dental Health Foundation, http://web.archive.org/web/20031101162951/http://www.dentalhealth.org.uk/faqs/leafletdetail.php?LeafletID=50, pages 1-3, November 2003. * |
Colgate Professional, http://www.colgateprofessional.com/patienteducation/What-Is-Tooth-Sensitivity/article, pages 1-4, retrieved September 25, 2010. * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9717665B2 (en) | 2013-10-28 | 2017-08-01 | The Procter & Gamble Company | Tooth desensitizing oral care compositions, devices, and methods |
US10231913B2 (en) | 2013-10-28 | 2019-03-19 | The Procter & Gamble Company | Tooth desensitizing oral care compositions, devices, and methods |
WO2015067422A1 (en) * | 2013-11-07 | 2015-05-14 | Unilever Plc | Compositions and methods for treating tooth hypersensitivity |
US9927422B2 (en) | 2014-05-13 | 2018-03-27 | The Procter & Gamble Company | Method and device for measuring dentin permeability |
Also Published As
Publication number | Publication date |
---|---|
EP1187593B1 (en) | 2007-06-27 |
US6524558B2 (en) | 2003-02-25 |
AU5890800A (en) | 2001-01-09 |
US20020064504A1 (en) | 2002-05-30 |
US20160279042A1 (en) | 2016-09-29 |
EP1187593A1 (en) | 2002-03-20 |
WO2000078270A1 (en) | 2000-12-28 |
ATE365526T1 (en) | 2007-07-15 |
US20080233054A1 (en) | 2008-09-25 |
PT1187593E (en) | 2007-09-26 |
CY1108058T1 (en) | 2014-02-12 |
CA2377598A1 (en) | 2000-12-28 |
DK1187593T3 (en) | 2007-10-29 |
ES2288862T3 (en) | 2008-02-01 |
DE60035344T2 (en) | 2008-02-14 |
US6436370B1 (en) | 2002-08-20 |
US20140120142A1 (en) | 2014-05-01 |
CA2377598C (en) | 2011-01-18 |
DE60035344D1 (en) | 2007-08-09 |
US20030133885A1 (en) | 2003-07-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6524558B2 (en) | Dental anti-hypersensitivity composition and method | |
RU2549979C2 (en) | Composition and method of increasing fluoride absorption with application of bioactive glass | |
US9040025B2 (en) | Anti-senstivity, anti-caries, anti-staining, anti-plaque, ultra-mild oral hygiene agent | |
JPH1017449A (en) | Composition for hyperesthesia | |
US11617711B2 (en) | Compositions and methods for dental care | |
KR100308247B1 (en) | Compositions for cleaning oral cavity | |
US9333154B2 (en) | Dual component oral composition for enhancing remineralization of teeth | |
WO2021047900A1 (en) | Oral care composition | |
Mason | Dental hygiene | |
US11857654B2 (en) | NHAP containing oral composition | |
US9205036B2 (en) | Dental composition | |
TWI620575B (en) | Dental composition | |
Gaffar | Oral-care products | |
WO2021048041A1 (en) | Oral care composition | |
Mason | Dental and mouthwash preparations |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |